Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

2.2K
This study used in-silico strategies to identify Enumerated Etravirine as a promising therapeutic agent for HIV. Our findings on molecular interactions and dynamics support the rational design of novel NNRTIs as possible HIV treatment...
2.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

6.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

926
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
926

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted Protein Degradation for Agricultural Applications: Rationale, Challenges, and Outlook.

ACS bio & med chem Au·2025
Same author

Pioneering protein degradation for agricultural applications.

Communications biology·2025
Same author

Toward Dose Prediction at Point of Design.

Journal of medicinal chemistry·2024
Same author

Archaeological evidence of an ethnographically documented Australian Aboriginal ritual dated to the last ice age.

Nature human behaviour·2024
Same author

Future climate change effects on US forest composition may offset benefits of reduced atmospheric deposition of N and S.

Global change biology·2023
Same author

SMILES Pair Encoding: A Data-Driven Substructure Tokenization Algorithm for Deep Learning.

Journal of chemical information and modeling·2021
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational Risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
Same journal

Balancing optimism versus potential risks of AI-driven drug discovery.

Expert opinion on drug discovery·2026
Same journal

Trustworthy and explainable AI for drug discovery.

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

4D- quantitative structure-activity relationship modeling: making a comeback.

Denis Fourches1, Jeremy Ash1

  • 1Department of Chemistry, Bioinformatics Research Center, North Carolina State University , Raleigh , NC , USA.

Expert Opinion on Drug Discovery
|September 13, 2019
PubMed
Summary
This summary is machine-generated.

Four-dimensional Quantitative Structure-Activity Relationship (4D-QSAR) modeling, enhanced by GPU-accelerated molecular dynamics and machine learning, offers improved prediction of chemical properties. This advanced approach, known as MD-QSAR, addresses limitations of traditional methods for drug discovery.

Keywords:
4D descriptorsQSARcheminformaticsmolecular dynamics

More Related Videos

Structure-Activity Relationships and Drug Design
01:28

Structure-Activity Relationships and Drug Design

1.7K
4D Microscopy of Yeast
12:00

4D Microscopy of Yeast

Published on: April 28, 2019

9.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Structure-Activity Relationships and Drug Design
01:28

Structure-Activity Relationships and Drug Design

1.7K
4D Microscopy of Yeast
12:00

4D Microscopy of Yeast

Published on: April 28, 2019

9.2K

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Molecular modeling

Background:

  • Traditional 2D/3D QSAR models struggle with conformation-dependent molecular properties and dynamic interactions.
  • These limitations reduce prediction performance and interpretability, particularly during lead optimization.
  • Conformation-dependent 4D-QSAR methods were developed to address these issues but faced computational cost challenges.

Purpose of the Study:

  • To review the literature on 4D-QSAR modeling.
  • To describe the modern MD-QSAR workflow.
  • To highlight current challenges and limitations in 4D-QSAR.

Main Methods:

  • Review of existing literature on 4D-QSAR.
  • Description of the MD-QSAR workflow integrating molecular dynamics and machine learning.
  • Discussion of computational advancements enabling modern 4D-QSAR.

Main Results:

  • 4D-QSAR is experiencing a resurgence due to advances in GPU-accelerated simulations and machine learning.
  • The MD-QSAR workflow offers a modern approach to conformation-dependent modeling.
  • Hyper-predictive MD-QSAR models show potential for disruptive impact.

Conclusions:

  • MD-QSAR represents a significant advancement for analyzing dynamic protein-ligand interactions.
  • This technology has broad applications in drug discovery and chemical toxicity assessment.
  • Engaging with hyper-predictive MD-QSAR modeling is highly relevant for molecular modeling teams.